Anti-Depressants and Anxiety
Antihistamines
Blocking Agents
Paid and Inflammation
  Home > Drug News > Vioxx Sufferers and Their Families have Hope for Justice



 

Pharmaceutical Courses

 
Pharmacy Technician
Allied College
Arnold, MO
Pharmacy Technician
Allied College
Saint Ann, MO
Pharmacy Technician
Cambridge College
Portland, OR
Pharmacy Technician
Cambridge College
Seattle, WA
Pharmacy Technician
High Tech Institute
Irving, TX
Pharmacy Technician
High Tech Institute
Atlanta, GA
Pharmacy Technician
High Tech Institute
Memphis, TN
Pharmacy Technician
High Tech Institute
Minneapolis, MN
Pharmacy Technician
High Tech Institute
Orlando, FL
Pharmacy Technician
High Tech Institute
Sacramento, CA
Pharmacy Technician
The Bryman School
Phoenix, AZ
 

Vioxx Sufferers and Their Families have Hope for Justice

Advertising Information for rxboomer
To support those adversely affected by Vioxx, attorneys advertising on LawyersandSettlements.com continue to accept formal complaints from consumers and their loved ones.

Angleton, Texas (PRWEB) August 24, 2005 -- The first of over 4,200 pending lawsuits has been won against Merck & Co., the maker of the controversial pain killer Vioxx. The jury awarded $253 million in damages to the widow of a man who died unexpectedly from a sudden change in heartbeat rhythm while taking Vioxx.

This plaintiff is not alone. Since 2002, LawyersandSettlements.com has received over 3,000 consumer complaints linking Vioxx with various health conditions and heart diseases. LawyersandSettlements.com is a privately held Internet marketing company that specializes in joint advertising campaigns for lawyers and law firms. LawyersandSettlements.com has a pulse on current legal news and settlement outcomes.

In September 2004, more than five years since its launch, Vioxx was quickly removed from pharmacy shelves. This voluntary action from Merck was induced by pressure from the FDA and the results from a three-year clinical study which indicated an increased risk of heart attack and stroke caused by Vioxx.

Vioxx is among a new class of Cox-2 inhibitor drugs which are typically prescribed to those with acute and chronic pain, such as arthritis, osteoarthritis, and back pain. At the time of the recall, Vioxx was being used by over two million people worldwide.

As more Vioxx complaints are submitted to LawyersandSettlements.com, analysts predict that Merck’s total liability may reach $18 billion from new and pending state and federal lawsuits. Merck has vowed to fight the upcoming lawsuits and appeal the current verdict in Texas. Despite the 2004 losses from the Vioxx product recall and the current pending lawsuits, Merck & Co. earns over $22 billion in annual revenues.

Back to Drug News

 
 
Antibiotics
Bisphosphonates
Oral Contraceptives and Menopause
Advertise Now
Infinit-i